Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-287312
Filing Date
2020-11-06
Accepted
2020-11-06 06:07:14
Documents
3
Period of Report
2020-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d68546d6k.htm 6-K 36403
2 GRAPHIC g68546g1111171418263.jpg GRAPHIC 8035
3 GRAPHIC g68546g94w00.jpg GRAPHIC 2852
  Complete submission text file 0001193125-20-287312.txt   52771
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 201292292
SIC: 2834 Pharmaceutical Preparations